We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesStemtech Corporation

Stemtech Corporation

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-12T14:44:00Z
VOLUME
576960
Market Cap
0.30M

Momentum Score

…

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
-
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
2.40M
Revenue Per Share
0.00
Gross Profit TTM
1.86M
Debt / Equity
-0.43
ROE
-
Net Debt
3.92M
ROCE
35.16%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -4.05M -3.77M -5.43M -8.54M -7.11M
Minority interest 0.00M 0.00M 0.00M 0.09M 0.03M
Net income -4.05M -3.77M -5.43M -8.54M -7.08M
Selling general administrative 4.58M 5.33M 6.94M 8.42M 5.77M
Selling and marketing expenses - - - - 0.74M
Gross profit 2.31M 3.73M 3.92M 3.40M 3.30M
Reconciled depreciation 0.17M 0.42M 0.66M 0.45M 0.33M
Ebit - - - - 1.25M
Ebitda - - - -3.99M 1.58M
Depreciation and amortization - - - - 0.33M
Operating income -2.71M -2.39M -4.22M -5.02M -3.21M
Other operating expenses - - - - 7.53M
Interest expense 1.45M 1.58M 4.89M 4.10M 8.33M
Tax provision 0.00M 0.00M 0.00M 0.10M 0.00M
Net interest income -1.45M -1.58M -4.89M -4.10M -8.33M
Total revenue 2.88M 5.05M 4.92M 4.56M 4.32M
Total operating expenses 5.59M 7.44M 9.15M 9.58M 6.51M
Cost of revenue 0.57M 1.33M 1.00M 1.16M 1.02M
Total other income expense net 0.11M 0.19M 3.69M 0.58M -3.90M
Net income from continuing ops -4.05M -3.77M -5.43M -8.63M -7.11M
Net income applicable to common shares - - - - -7.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 3.15M 3.78M 3.68M 4.27M 5.72M
Intangible assets 2.21M 2.38M 2.71M 2.99M 3.41M
Other current assets 0.00M 0.20M 0.18M 0.29M 0.32M
Total liab 10.85M 9.01M 6.46M 7.44M 9.73M
Total stockholder equity -6.96M -4.48M -2.04M -2.43M -3.36M
Other current liab 0.84M 0.67M 0.14M 3.03M 4.22M
Common stock - - - - 0.04M
Capital stock 0.43M 0.14M 0.10M 0.05M 0.04M
Retained earnings -34.88M -30.83M -27.06M -21.63M -13.09M
Good will 0.47M 0.47M 0.47M 0.47M 0.47M
Other assets - - - - 0.04M
Cash 0.24M 0.26M 0.11M 0.13M 0.83M
Total current liabilities 10.85M 9.01M 6.46M 7.42M 9.39M
Net debt 3.92M 3.56M 3.37M 0.80M 0.62M
Short term debt - - - - 1.11M
Short long term debt 4.16M 3.82M 3.49M 0.93M 1.06M
Short long term debt total - - - - 1.45M
Other stockholder equity - - - - 10.12M
Property plant equipment - - - - 0.21M
Total current assets 0.46M 0.92M 0.40M 0.61M 1.60M
Net tangible assets - - - - -7.23M
Net receivables 0.00M 0.27M 0.06M 0.03M 0.01M
Long term debt - - - - 0.22M
Inventory 0.22M 0.20M 0.05M 0.16M 0.44M
Accounts payable 5.41M 4.25M 2.71M 2.94M 4.05M
Accumulated other comprehensive income - - - - -0.43M
Non currrent assets other - - - - 0.04M
Non current assets total 2.69M 2.86M 3.28M 3.65M 4.12M
Capital lease obligations 0.00M 0.00M 0.07M 0.14M 0.17M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00M 0.00M - 0.00M
Change to liabilities - - - - 1.22M
Net borrowings 0.29M 0.07M 1.77M - 2.63M
Total cash from financing activities 0.46M 1.08M 1.58M 0.34M 2.63M
Change to operating activities - - - - -0.02M
Net income -4.05M -3.77M -5.43M -8.54M -7.08M
Change in cash -0.02M 0.14M -0.02M -0.70M 0.70M
Begin period cash flow 0.26M 0.11M 0.13M 0.83M 0.13M
End period cash flow 0.24M 0.26M 0.11M 0.13M 0.83M
Total cash from operating activities -0.48M -0.60M -2.04M -1.22M -1.91M
Issuance of capital stock 0.00M 0.47M 0.00M 0.10M 0.00M
Depreciation 0.17M 0.42M 0.66M 0.45M 0.33M
Change to inventory -0.02M -0.15M 0.11M 0.28M -0.24M
Change to account receivables 0.27M -0.21M -0.03M -0.02M 0.02M
Other cashflows from financing activities - - - - 3.32M
Change to netincome - - - - 3.26M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 1.78M 1.38M 1.09M -0.34M 0.97M
Stock based compensation 0.44M 0.44M 0.44M 4.00M 1.03M
Other non cash items 1.18M 1.04M 4.87M 3.88M 2.83M
Free cash flow -0.48M -0.60M -2.04M -1.22M -1.91M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
STEK
Stemtech Corporation		 -
-%		 0.00 - - 0.12 - 1.85 4.84
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Stemtech Corporation

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its products under the RCM System, stemrelease3, and Stemflo MigraStem brands; oral health care under the OraStem brand; and rapid renew stem cell peptide night cream under the Collect One brand name, as well as Cellect One shield hypochlorous acid skin care products. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.

4851 Tamiami Trail North, Naples, FL, United States, 34103

954 715 6000

https://www.stemtech.com

Name Title Year Born
Mr. Charles S. Arnold CEO & Director 1952
Mr. John W. Meyer Pres, COO & Director 1955
Mr. James S. Cardwell Chief Financial Officer 1961
Mr. Alejandro Carrillo Managing Director of Latin Markets NA
Mr. Charles S. Arnold CEO & Director 1951
Mr. John W. Meyer President, COO & Director 1955
Ms. Shrilakshmi Vadlapatla Chief Financial Officer 1985
Mr. Tufan Obuz Chief Administrative Officer 1970
Mr. David E. Price Esq. Secretary 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…